Publications by authors named "Anna K Nowak"

100Publications

The role of psychosocial support in the experiences of people living with advanced cancer: A qualitative exploration of patients' perspectives.

Psychooncology 2020 Oct 10. Epub 2020 Oct 10.

School of Nursing, Midwifery and Paramedicine, Curtin University, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.5569DOI Listing
October 2020

Enhancing the efficacy of immunotherapy using radiotherapy.

Clin Transl Immunology 2020 10;9(9):e1169. Epub 2020 Sep 10.

National Centre for Asbestos Related Diseases Perth WA Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cti2.1169DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507442PMC
September 2020

Tamoxifen for hepatocellular carcinoma.

Cochrane Database Syst Rev 2020 08 3;8:CD001024. Epub 2020 Aug 3.

NHMRC Clinical Trials Centre and Sydney Cancer Centre, The University of Sydney, Camperdown, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD001024.pub3DOI Listing
August 2020

Sleep disturbance in people with brain tumours and caregivers: a survey of healthcare professionals' views and current practice.

Support Care Cancer 2020 Jul 25. Epub 2020 Jul 25.

South Western Sydney Clinical School, University of New South Wales, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-020-05635-2DOI Listing
July 2020

Incorporating competing risk theory into evaluations of changes in cancer survival: making the most of cause of death and routinely linked sociodemographic data.

BMC Public Health 2020 Jun 26;20(1):1002. Epub 2020 Jun 26.

Health Economics and Data Analytics, Faculty of Health Sciences, School of Public Health, Curtin University, Kent St, Bentley, 6102, Western Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12889-020-09084-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318745PMC
June 2020

Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking.

Neurooncol Pract 2020 Jan 27;7(1):31-37. Epub 2019 Aug 27.

Brain Cancer Biobanking Australia, National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npz036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104879PMC
January 2020

Bilateral murine tumor models for characterizing the response to immune checkpoint blockade.

Nat Protoc 2020 05 1;15(5):1628-1648. Epub 2020 Apr 1.

School of Biomedical Sciences, University of Western Australia, Crawley, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41596-020-0299-3DOI Listing
May 2020

Cost-Effectiveness of Subsequent Whole-Brain Radiotherapy or Hippocampal-Avoidant Whole-Brain Radiotherapy Versus Stereotactic Radiosurgery or Surgery Alone for Treatment of Melanoma Brain Metastases.

Appl Health Econ Health Policy 2020 10;18(5):679-687

Health Economics, National Drug and Alcohol Research Centre, University of New South Wales, 22-32 King street, Sydney, NSW, 2031, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40258-020-00560-1DOI Listing
October 2020

Antiangiogeneic Strategies in Mesothelioma.

Front Oncol 2020 18;10:126. Epub 2020 Feb 18.

Thoracic Oncology Department & CIC1425-CLIP2 Early Phase Cancer Clinical Trials Unit, University Hospital Bichat-Claude Bernard, Medical Faculty, University Paris-Diderot, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2020.00126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040194PMC
February 2020

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy.

Front Immunol 2020 18;11:223. Epub 2020 Feb 18.

Telethon Kids Institute, University of Western Australia, West Perth, WA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2020.00223DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040078PMC
February 2020

Management of glioblastoma: an Australian perspective.

Chin Clin Oncol 2020 Feb 20. Epub 2020 Feb 20.

NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; The Preston Robert Tisch Brain Tumor Center and Duke Center for Cancer Immunotherapy, Duke University, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2020.02.05DOI Listing
February 2020

A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesothelioma.

Lung Cancer 2020 02 31;140:87-92. Epub 2019 Dec 31.

Department of Medical Oncology, Sir Charles Gairdner Hospital, Hospital Ave, Nedlands, Western Australia, 6009, Australia; National Centre for Asbestos Related Diseases, University of Western Australia, Level 5, QQ Block, QEII Medical Centre, Western Australia, 6009, Australia; Institute for Respiratory Health, University of Western Australia, Sir Charles Gairdner Hospital Avenue, Nedlands, Western Australia, 6009, Australia; Medical School, University of Western Australia, 35 Stirling Hwy, Crawley, Western Australia, 6009, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.12.018DOI Listing
February 2020

Immunotherapy trials in mesothelioma - promising results, but don't stop here.

Nat Rev Clin Oncol 2019 12;16(12):726-728

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-019-0291-4DOI Listing
December 2019

Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trial.

J Clin Neurosci 2019 Dec 30;70:157-163. Epub 2019 Sep 30.

Prince of Wales Clinical School, Cure Brain Cancer Biomarkers and Translational Research Group, University of New South Wales, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2019.08.044DOI Listing
December 2019

Taxanes for adjuvant treatment of early breast cancer.

Cochrane Database Syst Rev 2019 09 2;9:CD004421. Epub 2019 Sep 2.

Systematic Reviews and Health Technology Assessments, NHMRC Clinical Trials Centre, The University of Sydney, Locked Bag 77, Sydney, NSW, Australia, 1450.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD004421.pub3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718224PMC
September 2019

Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment.

J Clin Neurosci 2019 Oct 29;68:45-50. Epub 2019 Jul 29.

La Trobe University School of Cancer Medicine, Melbourne, Australia; Olivia Newton-John Cancer Wellness and Research Centre, Melbourne, Australia; Monash Health, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2019.07.063DOI Listing
October 2019

Reply to K. Masuda et al.

J Clin Oncol 2019 09 22;37(25):2294-2295. Epub 2019 Jul 22.

Dean A. Fennell, PhD, MD, University of Leicester and University Hospitals of Leicester National Health Service Trust, Leicester, United Kingdom; Paul Taylor, MD, Wythenshawe Hospital, Manchester, United Kingdom; David Gilligan, MD, Cambridge University Hospitals National Health Service Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom; Takashi Nakano, MD, PhD, Hyogo College of Medicine, Nishinomiya, Japan; Arnaud Scherpereel, MD, PhD, Calmette Hospital, Regional University Hospital of Lille, Lille, France; Nick Pavlakis, MD, PhD, Northern Cancer Institute, St Leonards, NSW, Australia; Jan P. van Meerbeeck, MD, PhD, Universitair Ziekenuis, Antwerp, Belgium; Joachim G.J.V. Aerts, MD, PhD, Erasmus Medical College, Rotterdam, the Netherlands; Anna K. Nowak, MD, PhD, University of Western Australia and Sir Charles Gairdner Hospital, Perth, WA, Australia; Hedy Kindler, MD, University of Chicago Medical Center, Chicago, IL; and Paul Baas, MD, PhD, Netherlands Cancer Institute, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01208DOI Listing
September 2019

Targeting angiogenesis for patients with unresectable malignant pleural mesothelioma.

Semin Oncol 2019 04 18;46(2):145-154. Epub 2019 Jun 18.

Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2019.06.001DOI Listing
April 2019

Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).

J Patient Rep Outcomes 2019 Jun 17;3(1):34. Epub 2019 Jun 17.

Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1450, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s41687-019-0122-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579804PMC
June 2019

Immune checkpoint inhibition for the treatment of mesothelioma.

Expert Opin Biol Ther 2019 07 2;19(7):697-706. Epub 2019 May 2.

a National Centre for Asbestos Related Diseases , University of Western Australia , Crawley , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2019.1606209DOI Listing
July 2019

Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF).

Sci Rep 2019 02 27;9(1):2905. Epub 2019 Feb 27.

Cure Brain Cancer Foundation Biomarkers and Translational Research Group, Prince of Wales Clinical School, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-39427-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393433PMC
February 2019

Patient preferences for adjuvant radiotherapy in early breast cancer are strongly influenced by treatment received through random assignment.

Eur J Cancer Care (Engl) 2019 Mar 14;28(2):e12985. Epub 2019 Jan 14.

Radiation Oncology Clinical Trials and Research Unit, Comprehensive Cancer Centre, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ecc.12985DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590655PMC
March 2019

Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors.

BMC Res Notes 2018 Dec 5;11(1):864. Epub 2018 Dec 5.

National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13104-018-3953-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282254PMC
December 2018

Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery.

J Thorac Oncol 2019 02 24;14(2):288-293. Epub 2018 Oct 24.

Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Australia; Curtin Medical School, Curtin University, Perth, Australia. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183318
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.10.005DOI Listing
February 2019

Combination immune checkpoint blockade as an effective therapy for mesothelioma.

Oncoimmunology 2018 30;7(10):e1494111. Epub 2018 Jul 30.

National Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/2162402X.2018.1
Publisher Site
http://dx.doi.org/10.1080/2162402X.2018.1494111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169578PMC
July 2018

Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1).

J Thorac Oncol 2018 07 9;13(7):1012-1021. Epub 2018 May 9.

Medical School and National Centre for Asbestos Related Diseases, University of Western Australia, Perth, Western Australia and Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183059
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.04.034DOI Listing
July 2018

Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A Trial.

Radiat Oncol 2018 Apr 13;13(1):68. Epub 2018 Apr 13.

Division of Surgery & Interventional Science, University College London, London W1W 7TS, UK; Whittington Hospital, Royal Free Hospital and University College Hospital, University College London, London, NW1 2FD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13014-018-0998-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899392PMC
April 2018

A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice.

BMC Cancer 2017 Oct 16;17(1):684. Epub 2017 Oct 16.

National Centre for Asbestos Related Diseases, University of Western Australia, 5th Floor, QQ Block, 6 Verdun Street, Nedlands, WA, 6009, Australia.

View Article

Download full-text PDF

Source
http://bmccancer.biomedcentral.com/articles/10.1186/s12885-0
Publisher Site
http://dx.doi.org/10.1186/s12885-017-3677-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644108PMC
October 2017

Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial.

J Clin Oncol 2017 Nov 11;35(31):3591-3600. Epub 2017 Sep 11.

Federica Grosso, Azienda Ospedaliera SS Antonio e Biagio General Hospital, Alessandria; Silvia Novello and Giorgio Scagliotti, L'università di Torino, Azienda Sanitaria Ospedale San Luigi Gonzaga, Turin, Italy; Anna K. Nowak, University of Western Australia, Crawley, and Sir Charles Gairdner Hospital, Nedlands, Western Australia; Thomas John, Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, Victoria, Australia; Sanjay Popat, The Royal Marsden Hospital National Health Service (NHS) Foundation Trust, London; Nicola Steele, The Beatson West of Scotland Cancer Centre, Glasgow; Paul Taylor, University Hospitals of South Manchester NHS Trust, Wythenshawe, Manchester, United Kingdom; Laurent Greillier, Assitance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille; David Planchard, Institut Gustave Roussy, Villejuif; Nassim Morsli, Boehringer Ingelheim France S.A.S., Paris, France; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Martin Reck, Lung Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf; Ute von Wangenheim, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; Jens Benn Sørensen, Rigshospitalet - Finsencentret, Copenhagen, Denmark; Mark A. Socinski, Florida Hospital Cancer Institute, Orlando, FL; Arsène Bienvenu Loembé, Boehringer Ingelheim B.V., Alkmaar, the Netherlands; and José Barrueco, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.9012DOI Listing
November 2017

Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial.

Neurooncol Pract 2017 Sep 25;4(3):171-181. Epub 2017 May 25.

Prince of Wales Hospital, Barker Street, Randwick, Sydney, NSW 2031, Australia (E.J.H.); University of New South Wales, Sydney, NSW 2052, Australia (E.J.H.); Royal Melbourne Hospital, Grattan Street, Parkville 3050, Melbourne Victoria, Australia (K.M.F., M.A.R., P.P., C.G.); Department of Medicine (Royal Melbourne Hospital), University of Melbourne, Grattan Street Parkville 3052, Victoria, Australia (K.M.F., M.A.R.); National Health and Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Sydney, NSW 2006, Australia (E.H.B., K.S., A.L., J.S.); Austin Hospital, 145 Studley Road, Heidelberg, Melbourne, Victoria 3084, Australia (L.C.); Sir Charles Gairdner Hospital, Nedlands, Perth 6009, Western Australia (A.K.N.); Royal North Shore Hospital, St Leonards, Sydney, NSW 2065, Australia (H.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npw025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655481PMC
September 2017

Corrigendum to "Fertilisers production from ashes after sewage sludge combustion-strategy towards sustainable development" [Environ. Res. 154 (2017) 171-180].

Environ Res 2017 10 26;158:815. Epub 2017 Jun 26.

Mineral and Energy Economy Research Institute, Polish Academy of Sciences, Ul. Wybickiego 7, Kraków, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.envres.2017.06.008DOI Listing
October 2017

Fertilisers production from ashes after sewage sludge combustion - A strategy towards sustainable development.

Environ Res 2017 Apr 10;154:171-180. Epub 2017 Jan 10.

The Mineral and Energy Economy Research Institute of the Polish Academy of Sciences, Ul. Wybickiego 7, Kraków, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.envres.2017.01.002DOI Listing
April 2017

Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity.

Nat Rev Drug Discov 2017 Apr 6;16(4):264-272. Epub 2017 Jan 6.

School of Medicine and Pharmacology and National Centre for Asbestos Related Diseases, University of Western Australia, 5th Floor QQ Block, 6 Verdun Street, Nedlands, Perth, Western Australia 6009, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrd.2016.233DOI Listing
April 2017

Distress and psychological morbidity do not reduce over time in carers of patients with high-grade glioma.

Support Care Cancer 2017 03 14;25(3):887-893. Epub 2016 Nov 14.

Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-016-3478-6DOI Listing
March 2017

Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group.

Lung Cancer 2016 11 5;101:48-58. Epub 2016 Sep 5.

School of Medicine and Pharmacology and National Centre for Asbestos Related Diseases, University of Western Australia, Perth, Western Australia and Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104184PMC
November 2016

Cosmesis and Breast-Related Quality of Life Outcomes After Intraoperative Radiation Therapy for Early Breast Cancer: A Substudy of the TARGIT-A Trial.

Int J Radiat Oncol Biol Phys 2016 09 23;96(1):55-64. Epub 2016 Apr 23.

School of Surgery, University of Western Australia, Western Australia, Australia; Genesis Cancer Care, Western Australia, Australia; Radiation Oncology, Comprehensive Cancer Centre, Sir Charles Gairdner Hospital, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.04.024DOI Listing
September 2016

Compliance with reporting guidelines by Australian pathologists: an audit of the quality of histopathology reporting in high-grade glioma.

Neurooncol Pract 2016 Jun 26;3(2):97-104. Epub 2015 Aug 26.

Sir Charles Gairdner Hospital, Department of Medical Oncology, Hospital Avenue, Nedlands, Perth, WA 6009, Australia (A.W., A.K.N.); Neuropathology Section, Department of Anatomical Pathology, Pathwest, Royal Perth Hospital, GPO Box X2213, Perth, WA 6001, Australia (V.F.); Cure Brain Cancer Neuro-oncology Laboratory, Prince of Wales Clinical School, Lowy Cancer Research Institute,2052UNSW Australia (K.M., T.A.N); School of Medicine and Pharmacology, University of Western Australia, 35 Stirling Highway Nedlands WA 6009, Australia (A.K.N., T.A.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npv033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668263PMC
June 2016

Carers of patients with high-grade glioma report high levels of distress, unmet needs, and psychological morbidity during patient chemoradiotherapy.

Neurooncol Pract 2016 Jun 15;3(2):105-112. Epub 2015 Oct 15.

Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia (A.L., A.K.N.); School of Nursing, Midwifery and Paramedicine, Faculty of Health Sciences, Curtin University, Bentley, Western Australia (G.K.B.H.); Calvary Health Care Kogarah and Cunningham Centre for Palliative Care, Sydney, New South Wales (E.A.L.); School of Medicine, The University of Notre Dame, Sydney, New South Wales (E.A.L.); Telethon Kids Institute, Perth, Western Australia (T.S.); Department of Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales (E.H.); Department of Medicine, University of New South Wales, Sydney, New South Wales (E.H.); School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia (A.K.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npv039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668264PMC
June 2016

Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies.

Oncoimmunology 2016 Mar 16;5(3):e1066062. Epub 2015 Sep 16.

School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia; National Centre for Asbestos Related Diseases, Perth, WA, Australia.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/2162402X.2015.1
Publisher Site
http://dx.doi.org/10.1080/2162402X.2015.1066062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839331PMC
March 2016

Human mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomes.

Oncoimmunology 2016 Feb 31;5(2):e1082028. Epub 2015 Aug 31.

School of Biomedical Sciences, Immunology and Cancer Group, Curtin University, Perth, Western Australia (WA), Australia; CHIRI Biosciences Research Precinct, Curtin University, Perth, WA, Australia.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/2162402X.2015.1
Publisher Site
http://dx.doi.org/10.1080/2162402X.2015.1082028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801471PMC
February 2016

PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitors.

Lung Cancer 2016 Mar 30;93:9-16. Epub 2015 Dec 30.

School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia; National Centre for Asbestos Related Disease, University of Western Australia, Crawley, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.12.006DOI Listing
March 2016

Malignant pleural mesothelioma: an update on diagnosis and treatment options.

Ther Adv Respir Dis 2016 06 12;10(3):275-88. Epub 2016 Feb 12.

School of Medicine and Pharmacology, University of Western Australia, M503 35 Stirling Hwy Crawley, WA 6009 Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1753465816628800DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933604PMC
June 2016

Asbestos exposure: challenges for Australian clinicians.

Med J Aust 2016 Feb;204(2):48-9

Sir Charles Gairdner Hospital, Perth, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja15.01072DOI Listing
February 2016

A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis.

J Thorac Oncol 2016 Apr 8;11(4):573-82. Epub 2016 Jan 8.

School of Medicine and Pharmacology, University of Western Australia, Perth, Australia; National Centre for Asbestos Related Diseases, University of Western Australia, Perth, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864160028
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2015.12.108DOI Listing
April 2016

Chemotherapy and immunotherapy: mapping the road ahead.

Curr Opin Immunol 2016 Apr 24;39:23-9. Epub 2015 Dec 24.

National Centre for Asbestos Related Diseases, University of Western Australia, Perth, Australia; School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2015.12.003DOI Listing
April 2016

Protocol for the Care-IS Trial: a randomised controlled trial of a supportive educational intervention for carers of patients with high-grade glioma (HGG).

BMJ Open 2015 Oct 26;5(10):e009477. Epub 2015 Oct 26.

Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjopen-2015-009477DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636639PMC
October 2015

Imaging in pleural mesothelioma: A review of the 12th International Conference of the International Mesothelioma Interest Group.

Lung Cancer 2015 Nov 29;90(2):148-54. Epub 2015 Jul 29.

Department of Radiology, The University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.07.011DOI Listing
November 2015

Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT.

Lung Cancer 2015 Oct 30;90(1):55-60. Epub 2015 Jul 30.

School of Medicine and Pharmacology, University of Western Australia, Crawley 6009 & Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.07.015DOI Listing
October 2015

Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations.

Sci Rep 2015 Jul 21;5:12298. Epub 2015 Jul 21.

1] National Centre for Asbestos Related Diseases [2] School of Medicine and Pharmacology, University of Western Australia, The Harry Perkins Institute of Medical Research, 5th Floor, QQ Block, 6 Verdun Street, Nedlands WA 6009, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep12298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508665PMC
July 2015

Restoration of defective cross-presentation in tumors by gemcitabine.

Oncoimmunology 2015 May 25;4(5):e1005501. Epub 2015 Feb 25.

School of Medicine and Pharmacology; The University of Western Australia ; Nedlands, WA, Australia ; National Centre for Asbestos Related Diseases ; Nedlands, WA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1005501DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485774PMC
May 2015

Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen.

Oncoimmunology 2015 Jul 11;4(7):e1011492. Epub 2015 May 11.

National Centre for Asbestos Related Diseases; School of Medicine and Pharmacology; University of Western Australia ; Nedlands, Australia ; Australian Mesothelioma Tumour Bank; Sir Charles Gairdner Hospital ; Nedlands, Australia ; Department of Respiratory Medicine; Sir Charles Gairdner Hospital ; Nedlands, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1011492DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485777PMC
July 2015

Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation.

Oncol Lett 2015 May 20;9(5):2063-2067. Epub 2015 Feb 20.

School of Pathology and Laboratory Medicine, University of Western Australia, Crawley WA 6009, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2015.2980DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467216PMC
May 2015

Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.

Neuro Oncol 2015 Nov 30;17(11):1504-13. Epub 2015 Jun 30.

Royal Melbourne Hospital, Parkville, Australia (K.M.F, P.M.P, M.A.R.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia (J.S., C.S.B.B., E.H.B, K.S., A.L.); Sir Charles Gairdner Hospital, Nedlands, Australia (A.K.N); School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia (A.K.N); Austin Health, Heidelberg, Australia (L.C., G.F.); Royal North Shore Hospital, St Leonards, Australia (H.W.); Prince of Wales Hospital, Randwick, Australia (E.J.H); University of New South Wales, Sydney, Australia (E.J.H); Monash Medical Centre, Clayton, Australia (R.F.); Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia (P.M.P., M.A.R., G.F.).

View Article

Download full-text PDF

Source
http://neuro-oncology.oxfordjournals.org/content/17/11/1504.
Web Search
http://neuro-oncology.oxfordjournals.org/lookup/doi/10.1093/
Publisher Site
http://dx.doi.org/10.1093/neuonc/nov104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648304PMC
November 2015

The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide.

Neuro Oncol 2015 Dec 24;17(12):1589-98. Epub 2015 Apr 24.

Cure Brain Cancer Neuro-oncology Laboratory, Prince of Wales Clinical School, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia (R.W.R., W.H., K.L.M.); Department of Medicine (Oncology), Stanford Cancer Institute, Stanford University, Stanford, California (F.W., M.P.H.); School of Public Health, Harbin Medical University, Harbin, People's Republic of China (F.W.); Department of Neurology, David Geffen School of Medicine at UCLA, University of California at Los Angeles, Los Angeles, California (H.N.N., T.F.C., A.L.); School of Medicine and Pharmacology, University of Western Australia, Perth, Australia (A.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633927PMC
December 2015

The potential role of exercise in neuro-oncology.

Front Oncol 2015 8;5:85. Epub 2015 Apr 8.

Edith Cowan University Health and Wellness Institute, Edith Cowan University , Joondalup, WA , Australia ; The University of Hong Kong , Hong Kong , China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2015.00085DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389372PMC
April 2015

Randomized Controlled Trial of Shared Care for Patients With Cancer Involving General Practitioners and Cancer Specialists.

J Oncol Pract 2015 Sep 10;11(5):349-55. Epub 2015 Mar 10.

The University of Western Australia; Harry Perkins Institute of Medical Research, The University of Western Australia; School of Primary, Aboriginal and Rural Health Care, The University of Western Australia; School of Medicine and Pharmacology, The University of Western Australia, Crawley; Royal Perth Hospital, Perth; General Practice and Primary Care Academic Centre, University of Melbourne, Carlton; Sir Charles Gairdner Hospital; Haematology Care Centre, Sir Charles Gairdner Hospital, Nedlands, Australia; and University of Oxford, Oxford, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2014.001569DOI Listing
September 2015

Predictors of distress and poorer quality of life in High Grade Glioma patients.

Patient Educ Couns 2015 Apr 14;98(4):525-32. Epub 2015 Jan 14.

Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia; School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2015.01.002DOI Listing
April 2015

Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy.

Eur J Immunol 2015 Jan 15;45(1):49-59. Epub 2014 Dec 15.

National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, The University of Western Australia, Nedlands, WA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201444722DOI Listing
January 2015

Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: evidence from an animal model and a human cohort.

Lung Cancer 2014 Oct 18;86(1):29-34. Epub 2014 Aug 18.

National Centre for Asbestos Related Diseases, University of Western Australia, Harry Perkins Institute for Medical Research, Nedlands, Perth, 6009 Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.08.005DOI Listing
October 2014

Observer variability in mesothelioma tumor thickness measurements: defining minimally measurable lesions.

J Thorac Oncol 2014 Aug;9(8):1187-94

Departments of *Radiology and ‖Health Studies, The University of Chicago, Chicago, Illinois; †School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia; and Departments of ‡Medical Oncology and §Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000211DOI Listing
August 2014

Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans.

PLoS One 2014 5;9(8):e103025. Epub 2014 Aug 5.

National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Harry Perkins Institute for Medical Research, Nedlands, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0103025PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122392PMC
April 2015

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma.

Thorax 2014 Oct 18;69(10):895-902. Epub 2014 Jul 18.

National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia The Australian Mesothelioma Tissue Bank, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://thorax.bmj.com/content/early/2014/07/18/thoraxjnl-201
Web Search
http://thorax.bmj.com/cgi/doi/10.1136/thoraxjnl-2014-205205
Publisher Site
http://dx.doi.org/10.1136/thoraxjnl-2014-205205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174124PMC
October 2014

Chemoimmunotherapy: still waiting for the magic to happen.

Lancet Oncol 2014 Jul 19;15(8):780-1. Epub 2014 Jun 19.

School of Medicine and Pharmacology University of Western Australia, Crawley 6009, WA, Australia; National Research Centre for Asbestos Related Diseases, University of Western Australia, Crawley, WA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(14)70267-0DOI Listing
July 2014

Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?

Future Oncol 2014 May;10(7):1137-45

Department of Medical Oncology, Azienda USL Bellaria-Maggiore Hospital, Via Altura 3, Bologna, 40139, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.14.75DOI Listing
May 2014

Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.

J Clin Pathol 2014 Jul 2;67(7):550-5. Epub 2014 Apr 2.

Cure Brain Cancer Neuro-oncology Group, Prince of Wales Clinical School, UNSW Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2014-202173DOI Listing
July 2014

Dietary vitamin D supplementation does not reduce the incidence or severity of asbestos-induced mesothelioma in a mouse model.

Nutr Cancer 2014 24;66(3):383-7. Epub 2014 Feb 24.

a National Centre for Asbestos Related Diseases , University of Western Australia , QEII Medical Centre, Nedlands , Perth , Australia.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.1080/01635581.2013.878
Publisher Site
http://dx.doi.org/10.1080/01635581.2013.878733DOI Listing
May 2015

Intraoperative radiotherapy for early breast cancer: do health professionals choose convenience or risk?

Radiat Oncol 2014 Jan 25;9:33. Epub 2014 Jan 25.

University of Western Australia PhD Candidate, School of Medicine and Pharmacology, Comprehensive Cancer Centre, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia.

View Article

Download full-text PDF

Source
http://ro-journal.biomedcentral.com/articles/10.1186/1748-71
Publisher Site
http://dx.doi.org/10.1186/1748-717X-9-33DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907143PMC
January 2014